Term
|
Definition
All infants over 2000 g: At birth, 3 doses total, last not before 6 months
Less than 2000 g with Hep B neg mother: Defer until 1 month or hospital discharge, 2 additional doses
Hep B positive mother: Hep B and HBIG regardless of age or size
Less than 2000 g and mother unknown: Vaccine and HBIG, 3 additional doses
Greater than 2000 g and mother unknown: Hep B; HBIG can be delayed up to 7 days |
|
|
Term
|
Definition
DTaP or DT ages under 7
TD or Tdap 7-10 years
Tdap 11 and older
Catch up: 4 doses only if 4th dose given after 4th birthday |
|
|
Term
|
Definition
Tdap for 11-18 years
Can be used in 7-10 years if un or underimmunized for pertussis
Local swelling, fever, anaphylaxis, seizure, crying, swelling, GBS
Less with acellular vaccine
Contra: severe anaphylaxis, severe encephalopathy within 7 days, progressive neuro disorder |
|
|
Term
|
Definition
Live attenuated
Can be given as young as 6 mos with outbreak, but will require 3rd dose
Fever, febrile seizure, rash, thrombocytopenia, encephalitis
Contra: pregnancy, anaphylaxis, immunosuppressed (not including HIV)
Delayed dose following IG
Vaccines must be 4 weeks apart |
|
|
Term
|
Definition
Live attenuated
Lymphadenopathy, fever, rash, arthralgias, arthritis
Contra: Pregnancy, immunocompromised (not including HIV) |
|
|
Term
|
Definition
Only IPV available in US
Catch up: 3 doses only if 3rd dose administered after 4th birthday
Contra: Severe streptomycin allergy |
|
|
Term
|
Definition
70-85% against even mild varicella
12 mos and 4 yrs but can be 4 wks apart
Anyone over age 12 can receive it
Rash
Contra: Pregnancy, T-cell immunocompromised pt (HIV OK if not severe), anaphylaxis to neomycin, concurrent illness
Delay following IG |
|
|
Term
|
Definition
Conjugated
Now recommended 4 doses by 15 mos
Healthy children 2-5 years who are not fully vaccinated should receive 1 dose
Single dose should be given age 6-18 years with chronic medical conditions such as cochlear implant, HIV, SSC, congenital heart disease, or 2 doses if underimmunized |
|
|
Term
|
Definition
Unconjugated
Not to be given under age 2 yrs
Given to children at risk
Give additional dose after 5 years to immunocompromise, sickle cell, asplenia
Adults over 65 years of age with chronic medical conditions |
|
|
Term
| Risk factors for invasive pneumococcal disease |
|
Definition
| Sickle cell, asplenia, alaskan natives, HIV, congenital immunodeficiency, cochelar implants, CSF leaks, chronic cardiac disease, renal failure, chronic pulmonar disease, DM, immunosuppresives |
|
|
Term
| FluMist contraindications |
|
Definition
| Salicylates, GBS, chronic medical conditions, egg hypersensitivity, age less than 2 years |
|
|
Term
|
Definition
Not under 2 years of age
Recommended beginning age 11 for all
Booster at age 16 years
Conjugate vaccine always preferred over polysaccharide
Contains strains A, C, W, Y
Recommended in asplenia, complement deficiency, endemic area, HIV |
|
|
Term
|
Definition
Live attenuated
Should be started by 15 weeks, at least 4 weeks apart and completed by 8 months
Contra: altered immunity, moderate to severe illness, GI disease, intussusception, spina bifida, severe latex allergy |
|
|
Term
|
Definition
Bats, racoons, foxes, skunks: treat unless proven otherwise
Dogs, cats, ferrets: Observe for 10 days and treat with any suspicion
Rodents, rabbits, livestock: No tx
Local wound care, rabies Ig, rabies vaccine (3 additional repeat doses) |
|
|
Term
|
Definition
Primary series starting at 2 months
Booster dose at 12-15 months
Upper age of 59 mos unless immunocompromised
Catch-up: 2 doses if 12-14 months, one dose if 15-59 mos |
|
|
